STERIS plc

Company Profile

STERIS plc had its IPO on 1992-06-01 under the ticker symbol STE.

The company operates in the Healthcare sector and Medical Devices industry. STERIS plc has a staff strength of 17,000 employees.

Stock update

Shares of STERIS plc opened at $228.18 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $226 - $228.64, and closed at $226.86.

This is a -0.84% slip from the previous day's closing price.

A total volume of 175,983 shares were traded at the close of the day’s session.

In the last one week, shares of STERIS plc have slipped by -1.51%.

STERIS plc's Key Ratios

STERIS plc has a market cap of $22.60 billion, indicating a price to book ratio of 3.3329 and a price to sales ratio of 3.9259.

In the last 12-months STERIS plc’s revenue was $5.09 billion with a gross profit of $2.16 billion and an EBITDA of $1.36 billion. The EBITDA ratio measures STERIS plc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, STERIS plc’s operating margin was 15.86% while its return on assets stood at 4.59% with a return of equity of 1.89%.

In Q2, STERIS plc’s quarterly earnings growth was a positive 13.6% while revenue growth was a positive 11.1%.

STERIS plc’s PE and PEG Ratio

Forward PE

23.2558

Trailing PE

189.0744

PEG

6.8839

Its diluted EPS in the last 12-months stands at $1.21 per share while it has a forward price to earnings multiple of 23.2558 and a PEG multiple of 6.8839. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into STERIS plc’s profitability.

STERIS plc stock is trading at a EV to sales ratio of 4.6647 and a EV to EBITDA ratio of 28.7588. Its price to sales ratio in the trailing 12-months stood at 3.9259.

STERIS plc stock pays annual dividends of $1.88 per share, indicating a yield of 0.91% and a payout ratio of 23.23%.

Balance sheet and cash flow metrics

Total Assets

$10.78 billion

Total Liabilities

$886.91 million

Operating Cash Flow

$-66596000.00

Capital Expenditure

$66.60 million

Dividend Payout Ratio

23.23%

STERIS plc ended 2024 with $10.78 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $10.78 billion while shareholder equity stood at $6.18 billion.

STERIS plc ended 2024 with $0 in deferred long-term liabilities, $886.91 million in other current liabilities, 4498212000.00 in common stock, $1.98 billion in retained earnings and $3.89 billion in goodwill. Its cash balance stood at $208.61 million and cash and short-term investments were $208.61 million. The company’s total short-term debt was $63,438,000 while long-term debt stood at $2.86 billion.

STERIS plc’s total current assets stands at $2.03 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $887.76 million compared to accounts payable of $260.69 million and inventory worth $768.84 million.

In 2024, STERIS plc's operating cash flow was $-66596000.00 while its capital expenditure stood at $66.60 million.

Comparatively, STERIS plc paid $0.23 in dividends in 2024.

Other key metrics

Current Trading Price

$226.86

52-Week High

$253.4094

52-Week Low

$157.6311

Analyst Target Price

$225.17

STERIS plc stock is currently trading at $226.86 per share. It touched a 52-week high of $253.4094 and a 52-week low of $253.4094. Analysts tracking the stock have a 12-month average target price of $225.17.

Its 50-day moving average was $226.11 and 200-day moving average was $201.81 The short ratio stood at 4.23 indicating a short percent outstanding of 0%.

Around 27.2% of the company’s stock are held by insiders while 9735.1% are held by institutions.